Cornea Ectasia Excimer Laser Treatment

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 31, 2019

Study Completion Date

April 30, 2020

Conditions
Corneal Ectasia
Interventions
PROCEDURE

topographic guided trans epithelial excimer laser

In this retrospective study 8 eyes affected by cornea ectasia of 8 patients (mean age 31.50±14.73 years) underwent simultaneous CCR and CXL. Preoperative and 6 month postoperative uncorrected distance visual acuity (UDVC) and distance corrected visual acuity (DCVA) were measured using the Efficacy and Safety index. Objective and subjective quality of vision were respectively evaluated through preoperative and 6 month postoperative corneal morphological irregularity index (CMI), National Eye Institute Visual Function NEI-VFQ25 and NEI-VFQ39 questionnaires.

Trial Locations (1)

00195

Luca buzzonetti, Roma

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT04405882 - Cornea Ectasia Excimer Laser Treatment | Biotech Hunter | Biotech Hunter